Spotlight
Interventional Cardiology

Learn about Interventional Cardiology and the subspecialty trained cardiologists at Wake Forest Baptist Health's Heart Center.

MORE

Profile

Renato Maria Santos, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-7382
Fax:
336-716-5324
Clinical Specialties
Cardiology (clinical), Cardiology (interventional)
Education & Training
  BAUniversity of Iowa1985
  MDUniversity of Iowa1990
ResidencyInternal MedicineDuke University1993
InternshipInternal MedicineDuke University1991
FellowshipCardiologyDuke University1996
  CardiologyDuke University1997
Board Certifications
American Board of Internal Medicine , Cardiovascular Disease
American Board of Internal Medicine , Internal Medicine
Memberships
North Carolina Medical Society
American Board of Internal Medicine
American Coll of Cardiology
American Coll of Physicians
Alpha Omega Alpha
NPI Number
1295710481

Renato Maria Santos, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-7382
Fax:
336-716-5324
Recent Publications
Dubose TD Jr, Santos RM. Vascular disorders of the kidney. In: Goldman L, Schafer AI, eds. Goldman's Cecil medicine, vol 1. 24th ed. Philadelphia: Elsevier/Saunders; 2012: 783-788.

Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Circ Cardiovasc Qual Outcomes. 2011; 4(4):408-415.

Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ. Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl 1):E1057.

Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ. Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl 1):E1184.

Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ. Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl):E1269.

Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ. Resource utilization for propensity matched radial and femoral catheterization and intervention [abstract]. J Am Coll Cardiol. 2011; 58(20 Suppl B):B146-B147.

Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010; 22(6):266-270.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009; 2():35-42.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol Intv. 2009; 2(3):231-239.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Three-year comparison of drug-eluting versus bare metal stents [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A353.

Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A317-A318.

Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J. 2009; 157(4):688-694.

Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A319.

Santos RM, Sacrinty MJ, Kutcher MA, Gandhi SK, Little WC, Applegate RJ. Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A393-A394.

Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009; 74(1):64-73.

DuBose TD Jr, Santos RM. Vascular disorders of the kidney. In: Goldman L, Ausiello D, eds. Cecil medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2008: 891-897.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. 'Off-label' stent therapy. J Am Coll Cardiol. 2008; 51(6):607-614.

Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008; 20(5):224-228.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B78.

Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC. Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B1.

Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA. Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B61.

Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv. 2008; 1(3):317-326.

Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Late outcomes of drug-eluting versus bare meta stents in saphenous vein grafts: propensity score analysis. Catheter Cardiovasc Interv. 2008; 72(1):7-12.

Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA. Incidence of coronary stent thrombosis based on academic research consortium definitions. Am J Cardiol. 2008; 102(6):683-688.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Prognostic implications of post percutaneous coronary intervention vascular complications [abstract]. Am J Cardiol. 2008; 102(8A Suppl):9i.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007; 99(3):333-338.

Echols MR, Mahaffey KW, Banerjee A, Pieper KS, Stebbins A, Lansky A, Cohen MG, Velazquez E, Santos R, Newby LK, et al. Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial). Am J Cardiol. 2007; 99(3):315-321.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaeous coronary intervention using thrombin hemostatic patch-facilitated manual compression. J Invasive Cardiol. 2007; 19(4):164-170.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Vascular complications following cardiac catheterization and coronary intervention 1998-2005: influence of gender [abstract]. J Am Coll Cardiol. 2007; 49(9 Suppl):193A.

Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV Jr, Antman E, Aylward P, Santos R, Hoekstra JW, et al. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J. 2007; 28(9):1079-1084.

Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV Jr, Ohman EM, Gibler WB, Peterson ED. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med. 2007; 120(8):685-692.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR, Santos RM, Little WC. Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. J Invasive Cardiol. 2007; 19(9):369-374.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Vascular complications 1998-2007: evidence for better outcomes [abstract]. Am J Cardiol. 2007; 100(8 Suppl 1):6L.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Baki TT, Gandhi SK, Little WC. Off-label DES vs. BMS treatment: outcomes at 2 years [abstract]. Am J Cardiol. 2007; 100(8 Suppl 1):159L.

Call J, Sacrinty M, Applegate R, Little W, Santos R, Baki T, Gandhi S, Kahl F, Kutcher M. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol. 2006; 18(10):469-474.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Circulation. 2006; 114(18 Suppl):II-392.

Echols MR, Banerjee A, Cohen MG, Santos R, Newby LK, Gurfinkel EP, Biasucci L, Mahaffey KW. Racial differences in high-risk patients presenting with NSTE ACS: results from the SYNERGY trial [abstract]. Eur Heart J. 2006; 27(Suppl 1):110.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Am J Cardiol. 2006; 98(8A Suppl):184M-185M.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Drug-eluting stent treatment of patients with myocardial infarction--efficacy and safety at nine months [abstract]. Am J Cardiol. 2006; 98(8A Suppl):75M.

Leonard JC, Sacrinty MT, Applegate RJ, Little WC, Baki TT, Gandhi SK, Santos RM, Kutcher MA. Timing of intervention in non-ST-segment elevation myocardial infarctions: nine month outcomes [abstract]. Am J Cardiol. 2006; 98(8A Suppl):80M-81M.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Renato Maria Santos, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-7382
Fax:
336-716-5324

 

Last Updated 1/19/2012
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Find a Doctor

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.